Lynda Charters

Topical oxymetazoline HCL ophthalmic solution 0.1% (RVL-1201, RVL Pharmaceuticals, Inc.) has the potential to treat patients with varying degrees of severity of acquired ptosis compared with vehicle.

Massachusetts researchers are reporting structural disparities in vaccine distribution in the state.

Technology can track the progression of retinal abnormalities

Researchers conducting a case-control surveillance of COVID-19 vaccination during pregnancy found that spontaneous abortions did not increase as a result of vaccinations.

Researchers found that the effectiveness of the vaccine held for about 6 months in most adults, but began to be less effective at that time point.

Unilateral ptosis can be the first symptom related to other causes that are traumatic, myogenic, neurogenic, or mechanical in nature.

CXL is safe, effective to perform on younger population, study results show.

Marta Belmonte-Grau, MD discusses the potential risk for posterior capsular rupture during cataract surgery.

Anat Loewenstein, MD, MHA, discusses how artificial intelligence can optimize optical coherence tomography.

A case study details the care of a patient who had already lost vision in one eye from a similar issue.

A 48-year-old male patient presented to an ophthalmic emergency department with what was described as progressive bilateral corneal melting 5 weeks after he received the first dose of a COVID-19 vaccine.

José-Alain Sahel, MD, explains how optogenetics involves artificial photoreceptors from specific retinal cells to restore vision.

The new virtual conference will debut on Sept. 18, and can help young ophthalmologists solve the small problems before they become bigger problems.

Why instillation of topical corticosteroids may be associated with greater ptosis and higher rate of failed ptosis repair

A study in the United Arab Emirates reported a possible link between adverse ocular events and a COVID-19 vaccination.

Development of new animal model enhances study of potential mutations.

Scanning laser ophthalmoscopy offers improved view of posterior segment.

Reports indicate the variant was first detected in Colombia in early 2021 and has currently spread to 39 countries including the United States.

Study examines immunomodulatory therapy as a potential long-term treatment option.

Investigators searched PubMed over the past 2 decades for clinical trials on eyelid ptosis using the terms blepharoptosis or upper eyelid ptosis or eyelid ptosis” and the filters “randomized controlled trial (RCT), clinical trial, and humans.”

Corticosteroids and antibiotics may be indicated in patients with severe rhinosinusitis until either IgG4-related or bacterial rhinosinusitis can be ruled out.

A team of investigators at McMaster University in Toronto has found that fluvoxamine reduced hospitalizations by up to 30 percent.

In PIONEER study, investigators outline their successes.

Experts provide perspectives on current care and pipeline products.

A team of UK researchers further examine the rare thrombocytopenia and thromboembolic events occurring after COVID-19 vaccinations.

Investigation evaluates safety of single and multiple intravitreal injections.

Regeneron Pharmaceuticals announced at an ongoing Phase 2 trial has met its primary safety endpoint with no new safety signals observed.

Researchers conducted a retrospective observational study to assess the corneal refractive changes induced by surgery to correct ptosis using Fourier harmonic analysis.

Advances help gain clearer image, enhancing decision-making process.

Investigators study the systemic adverse physiologic effects of the virus that causes COVID-19.